glp-1 medications mechanism of action Mechanisms and Therapeutic Application of Glucagon-like Peptide-1: Cell Metabolism Glucagon-like peptide-1 (GLP-1) receptor agonists

As you prepare for this next chapter, remember that you don't have to navigate the transition alone

Around 1520 min after a meal, levels of GLP-1 and GIP in the blood rise and stimulate receptors on pancreatic cells, leading to a glucose-dependent insulin response to process carbohydrates and fats

8 , e2457349 (2025)

Patients should discuss with their primary care physician and/or endocrinologist whether they should cease GLP-1 medication use in order to balance the risk of vision loss from NAION in the fellow eye with the hypoglycemic and cardiovascular benefits from treatment

Chorley, B.N., et al., Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha

The goal is always sustainable improvement in overall health not rapid or cosmetic weight loss